These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36463205)

  • 21. METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression.
    Wu Z; Wei N
    J Transl Med; 2023 Nov; 21(1):855. PubMed ID: 38012763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclopeptide moroidin inhibits vasculogenic mimicry formed by glioblastoma cells
    Min P; Li Y; Wang C; Fan J; Liu S; Chen X; Tang Y; Han F; Zhang A; Feng L
    J Biomed Res; 2024 May; 38(4):322-333. PubMed ID: 38807414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
    Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
    Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies.
    Angara K; Rashid MH; Shankar A; Ara R; Iskander A; Borin TF; Jain M; Achyut BR; Arbab AS
    Histol Histopathol; 2017 Sep; 32(9):917-928. PubMed ID: 27990624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased RNA m
    Tao M; Li X; He L; Rong X; Wang H; Pan J; Lu Z; Zhang X; Peng Y
    Am J Cancer Res; 2022; 12(2):893-906. PubMed ID: 35261810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SUMOylation of RALY promotes vasculogenic mimicry in glioma cells via the FOXD1/DKK1 pathway.
    Cao S; Wang D; Wang P; Liu Y; Dong W; Ruan X; Liu L; Xue Y; E T; Lin H; Liu X
    Cell Biol Toxicol; 2023 Dec; 39(6):3323-3340. PubMed ID: 37906341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness.
    Voss DM; Sloan A; Spina R; Ames HM; Bar EE
    Cancer Res; 2020 Nov; 80(21):4681-4692. PubMed ID: 32928918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
    Brunckhorst MK; Wang H; Lu R; Yu Q
    Cancer Res; 2010 Sep; 70(18):7283-93. PubMed ID: 20823154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
    Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
    Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
    Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
    Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
    Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
    Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircPITX1 Regulates Proliferation, Angiogenesis, Migration, Invasion, and Cell Cycle of Human Glioblastoma Cells by Targeting miR-584-5p/KPNB1 Axis.
    Cao Y; Wang F; Chen Y; Wang Y; Song H; Long J
    J Mol Neurosci; 2021 Aug; 71(8):1683-1695. PubMed ID: 33763840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
    Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
    Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
    [No Abstract]   [Full Text] [Related]  

  • 39. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry.
    Ren K; Zhang J; Gu X; Wu S; Shi X; Ni Y; Chen Y; Lu J; Gao Z; Wang C; Yao N
    Exp Cell Res; 2018 Aug; 369(1):80-89. PubMed ID: 29750896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasculogenic mimicry-potential target for glioblastoma therapy: an in vitro and in vivo study.
    Chen Y; Jing Z; Luo C; Zhuang M; Xia J; Chen Z; Wang Y
    Med Oncol; 2012 Mar; 29(1):324-31. PubMed ID: 21161444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.